まとめ
ヒトリンパ性細胞系 (LA 85.2) は,IgGを分泌するが,集結したIgMはプラズマ膜に留まっている. 新しい膜タンパク質が,この表面のIgMを固定し,免疫グロブリン生産と細胞機能に影響を及ぼしているようです.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
背景:
- ヒトリンパ性細胞系は,免疫グロブリン産生を研究するための重要なモデルである.
- B細胞受容体 (BCR) アセンブリと表面発現の調節を理解することは,免疫学にとって不可欠です.
研究 の 目的:
- 特定のヒトリンパ性細胞クローンにおける免疫グロブリンの生成と組み立てを調査するために,LA 85.2.2.
- この細胞系におけるIgMの表面表現を調節するメカニズムを特定する.
主な方法:
- 生物化学分析を用いた免疫グロブリン鎖 (ム,ガンマ,軽鎖) の生成の分析.
- IgMの蓄積と分泌の調査.
- 細胞表面タンパク質の特徴と,抗体-抗原複合体との相互作用.
主要な成果:
- LA 85.2細胞系は,IgGを分泌するが,IgMを分泌しない,mu,gamma,そして光鎖を産生する.
- 組み立てられた8S IgMは,プラズマ膜内に留まり,IgGよりも低い割合で生成されます.
- 抗体-抗原の沈殿物を結合できる新しい血膜タンパク質が特定されました.
結論:
- LA 85.2細胞系は,異常なIgMの集合と保持を研究するためのモデルを提供します.
- 特定されたプラズマ膜タンパク質は,表面のIgMをアンカーし,それをプラズマ膜に保持すると仮定されています.
- この保持メカニズムは,全体的な免疫グロブリン分泌と細胞シグナル伝達に影響を与える可能性があります.
関連する概念動画
Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
Lymphoid Cells and Tissues
3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Cells of the Adaptive Immune Response
6.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.9K
B Cell Activation and Differentiation
14.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.5K


